Volume | 4,042,120 |
|
|||||
News | - | ||||||
Day High | 157.60 | Low High |
|||||
Day Low | 155.35 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Johnson and Johnson | JNJ | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
157.37 | 155.35 | 157.60 | 156.88 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
85,416 | 4,042,120 | $ 156.18 | $ 631,307,477 | - | 150.11 - 181.039 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:30:22 | 90 | $ 155.74 | USD |
Johnson and Johnson (JNJ) Options Flow Summary
Johnson and Johnson Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
404.79B | 2.60B | - | 94.94B | 17.94B | 6.90 | 22.53 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Johnson and Johnson News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 161.30 | 161.40 | 155.255 | 158.43 | 6,935,445 | -5.55 | -3.44% |
1 Month | 161.54 | 165.27 | 155.255 | 160.73 | 7,344,323 | -5.79 | -3.58% |
3 Months | 160.60 | 175.97 | 155.255 | 168.46 | 24,410,094 | -4.85 | -3.02% |
6 Months | 152.24 | 175.97 | 152.07 | 166.71 | 14,986,501 | 3.51 | 2.31% |
1 Year | 166.48 | 181.039 | 150.11 | 166.57 | 11,103,807 | -10.73 | -6.45% |
3 Years | 147.60 | 186.69 | 133.65 | 165.98 | 8,541,358 | 8.15 | 5.52% |
5 Years | 138.26 | 186.69 | 109.16 | 155.53 | 8,220,411 | 17.49 | 12.65% |
Johnson and Johnson Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. |